We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-17.83%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$404B
AUM Growth
-$174B
Cap. Flow
-$8.47B
Cap. Flow %
-2.09%
Top 10 Hldgs %
31.86%
Holding
14,668
New
1,801
Increased
4,898
Reduced
5,771
Closed
1,897

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$824M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$459M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$301M
4
WBD icon
Warner Bros
WBD
+$287M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.22%
2 Technology 1.79%
3 Consumer Discretionary 1.52%
4 Communication Services 1.04%
5 Financials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLE icon
12301
PUT
Super League Enterprise
SLE
$181M
$19K ﹤0.01%
2
-2
-50% -$26K
PVLA
12302
PUT
Palvella Therapeutics
PVLA
$2.21B
$19K ﹤0.01%
+130
New +$23.7K
TTOO
12303
DELISTED
T2 Biosystems, Inc
TTOO
$19K ﹤0.01%
24
-2
-8% -$2.96K
IMV
12304
CALL
DELISTED
IMV Inc. Common Shares
IMV
$19K ﹤0.01%
2,930
+200
+7% +$2.07K
AGTC
12305
DELISTED
Applied Genetic Technologies Corporation
AGTC
$19K ﹤0.01%
25,051
-472
-2% -$421
EQOS
12306
CALL
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$19K ﹤0.01%
23,100
-29,800
-56% -$39.7K
YDKG
12307
CALL
Yueda Digital Holding
YDKG
$5.64M
$18K ﹤0.01%
30
+2
+7% +$1.11K
BBAI.WS icon
12308
BigBear.ai Holdings Warrant
BBAI.WS
$30.4M
$18K ﹤0.01%
43,932
+18
+0% +$14
BFRIW icon
12309
Biofrontera
BFRIW
$42.4K
$18K ﹤0.01%
+26,152
New +$28.8K
BKYI
12310
PUT
BIO-key International
BKYI
$4.61M
$18K ﹤0.01%
58
-246
-81% -$87.3K
CRDL
12311
Cardiol Therapeutics
CRDL
$238M
$18K ﹤0.01%
13,594
+644
+5% +$917
CYCN icon
12312
Cyclerion Therapeutics
CYCN
$18.6M
$18K ﹤0.01%
1,598
+606
+61% +$8.68K
MLSS icon
12313
Milestone Scientific
MLSS
$43.4M
$18K ﹤0.01%
19,786
+650
+3% +$663
TRAW icon
12314
Traws Pharma
TRAW
$9.17M
$18K ﹤0.01%
+534
New +$18K
WEJO
12315
PUT
DELISTED
Wejo Group Limited Common Shares
WEJO
$18K ﹤0.01%
15,000
+2,500
+20% +$5.84K
LCI
12316
PUT
DELISTED
Lannett Company, Inc.
LCI
$18K ﹤0.01%
7,700
+825
+12% +$2.05K
GIIXW
12317
DELISTED
Gores Holdings VIII, Inc. Warrant
GIIXW
$18K ﹤0.01%
+32,148
New +$26.7K
BLPH
12318
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$18K ﹤0.01%
+14,335
New +$19.2K
VISL
12319
CALL
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$18K ﹤0.01%
1,505
-365
-20% -$5.49K
CKPT
12320
DELISTED
Checkpoint Therapeutics
CKPT
$17K ﹤0.01%
1,665
-13,773
-89% -$180K
CRESW
12321
DELISTED
Cresud SACIF y A. Warrant
CRESW
$17K ﹤0.01%
33,542
+4,767
+17% +$2.4K
CRVS icon
12322
PUT
Corvus Pharmaceuticals
CRVS
$1.25B
$17K ﹤0.01%
17,200
-9,300
-35% -$11.4K
GLDG
12323
GoldMining Inc
GLDG
$245M
$17K ﹤0.01%
+17,700
New +$22.6K
LCTX icon
12324
PUT
Lineage Cell Therapeutics
LCTX
$291M
$17K ﹤0.01%
10,700
-43,400
-80% -$57.2K
PWCM
12325
PowerCompute Inc
PWCM
$1.18M
$17K ﹤0.01%
137
-182
-57% -$45.9K

Similar funds

Jeff Yass's Q2 2022 Portfolio in Review

As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
  • Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
  • Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
  • Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
  • Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
  • Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
  • Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.